{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:06:20Z","timestamp":1782817580313,"version":"3.54.5"},"reference-count":51,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2017\/005086"],"award-info":[{"award-number":["EMR\/2017\/005086"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["2020-7055\/CMB-BMS"],"award-info":[{"award-number":["2020-7055\/CMB-BMS"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMR\/2017\/005086"],"award-info":[{"award-number":["EMR\/2017\/005086"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2020-7055\/CMB-BMS"],"award-info":[{"award-number":["2020-7055\/CMB-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Corneal opacification or scarring is one of the leading causes of blindness worldwide. Human limbus-derived stromal\/mesenchymal stem cells (hLMSCs) have the potential of clearing corneal scarring. In the current preclinical studies, we aimed to determine their ability to heal the scarred corneas, in a murine model of corneal scar, and examined their ocular and systemic toxicity after topical administration to rabbit eyes. The hLMSCs were derived from human donor corneas and were cultivated in a clean room facility in compliance with the current good manufacturing practices (cGMP). Before the administration, the hLMSCs were analyzed for their characteristic properties including immunostaining, and were further subjected to sterility and stability analysis. The corneas (right eye) of C57BL\/6 mice (n = 56) were stripped of their central epithelium and superficial anterior stroma using a rotary burr (Alger Brush\u00ae II). Few mice were left untreated (n = 8), while few (n = 24) were treated immediately with hLMSCs after debridement (prophylaxis group). The rest (n = 24, scar group) were allowed to develop corneal scarring for 2 weeks and then treated with hLMSCs. In both groups, the treatment modalities included encapsulated (En+) and non-encapsulated (En\u2212) hLMSCs and sham (vehicle) treatment. The follow-up (4 weeks) after the treatment or debridement included clinical photography, fluorescein staining, and optical coherence tomography at regular intervals. All the images and scans were analyzed using ImageJ software to assess the changes in corneal haze, scar area, and the reflectivity ratio of the epithelium to the stroma. The scar area and the scar intensity were found to be decreased in the groups that received hLMSCs. The reflectivity of the stroma was found to be normalized to the baseline levels before the debridement in the eyes that were treated with hLMSCs, relative to the untreated. In the safety study, the central corneas of the left eye of 18 New Zealand rabbits were scraped with a needle and then treated with En+ hLMSCs, En\u2212 hLMSCs, and the sham (n = 6 each). Rabbits were then followed up for 4 weeks, during which blood and tear samples were collected at regular intervals. These rabbits were then assessed for changes in the quantities of inflammatory markers (TNF-\u03b1, IL-6, and IgE) in the sera and tears, changes in the ocular surface observations such as intraocular pressure (IOP), and the hematological and clinical chemistry parameters. Four weeks later, the rabbits were euthanized and examined histopathologically. No significant changes in conjunctival congestion, corneal clarity, or IOP were noticed during the ophthalmic examination. The level of inflammatory molecules (TNF-\u03b1 and IL-6 TNF-\u03b1) and the hematological parameters were similar in all groups without any significant changes. Histological examination of the internal organs and ocular tissues did not reveal any abnormalities. The results of these studies summarize that the En+ and En\u2212 hLMSCs are not harmful to the recipient and potentially restore the transparency of debrided or scarred corneas, indicating that hLMSCs can be assessed for clinical use in humans.<\/jats:p>","DOI":"10.3390\/cells12060876","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T06:52:13Z","timestamp":1678690333000},"page":"876","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pre-Clinical Evaluation of Efficacy and Safety of Human Limbus-Derived Stromal\/Mesenchymal Stem Cells with and without Alginate Encapsulation for Future Clinical Applications"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-3414","authenticated-orcid":false,"given":"Mukesh","family":"Damala","sequence":"first","affiliation":[{"name":"Centre for Ocular Regeneration (CORE), Prof Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad 500034, India"},{"name":"School of Life Sciences, University of Hyderabad, Hyderabad 500046, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-1852","authenticated-orcid":false,"given":"Abhishek","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Centre for Ocular Regeneration (CORE), Prof Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad 500034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Pakalapati","sequence":"additional","affiliation":[{"name":"Centre for Ocular Regeneration (CORE), Prof Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad 500034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3958-5635","authenticated-orcid":false,"given":"Vivek","family":"Singh","sequence":"additional","affiliation":[{"name":"Centre for Ocular Regeneration (CORE), Prof Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad 500034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-5003","authenticated-orcid":false,"given":"Sayan","family":"Basu","sequence":"additional","affiliation":[{"name":"Centre for Ocular Regeneration (CORE), Prof Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad 500034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1113\/jphysiol.1957.sp005758","article-title":"The Structure and Transparency of the Cornea","volume":"136","author":"Maurice","year":"1957","journal-title":"J. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.exer.2003.07.003","article-title":"The Organization of Collagen in the Corneal Stroma","volume":"78","author":"Meek","year":"2004","journal-title":"Exp. Eye Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"45629","DOI":"10.1074\/jbc.M303292200","article-title":"Keratocyte Phenotype Mediates Proteoglycan Structure: A Role for Fibroblasts in Corneal Fibrosis","volume":"278","author":"Funderburgh","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"266ra172","DOI":"10.1126\/scitranslmed.3009644","article-title":"Human Limbal Biopsy-Derived Stromal Stem Cells Prevent Corneal Scarring","volume":"6","author":"Basu","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_5","first-page":"140","article-title":"Characterization of Avascular Corneal Wound Healing Fibroblasts. New Insights into the Myofibroblast","volume":"127","author":"Jester","year":"1987","journal-title":"Am. J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2014.09.012","article-title":"The Corneal Fibrosis Response to Epithelial-Stromal Injury","volume":"142","author":"Torricelli","year":"2016","journal-title":"Exp. Eye Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.exer.2011.09.012","article-title":"Effect of TGF\u03b2 and PDGF-B Blockade on Corneal Myofibroblast Development in Mice","volume":"93","author":"Singh","year":"2011","journal-title":"Exp. Eye Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"108594","DOI":"10.1016\/j.exer.2021.108594","article-title":"TGF Beta -1, -2 and -3 in the Modulation of Fibrosis in the Cornea and Other Organs","volume":"207","author":"Wilson","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0161-6420(03)00463-9","article-title":"Long-Term Graft Survival after Penetrating Keratoplasty","volume":"110","author":"Thompson","year":"2003","journal-title":"Ophthalmology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ajo.2005.07.024","article-title":"The Impact of Corneal Allograft Rejection on the Long-Term Outcome of Corneal Transplantation","volume":"140","author":"Coster","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1097\/TP.0b013e3181903b0a","article-title":"All Contributors Risk Factors for Human Corneal Graft Failure within the Australian Corneal Graft Registry","volume":"86","author":"Williams","year":"2008","journal-title":"Transplantation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.stemcr.2016.09.001","article-title":"Restoration of Corneal Transparency by Mesenchymal Stem Cells","volume":"7","author":"Mittal","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1634\/stemcells.2004-0256","article-title":"Multipotent Stem Cells in Human Corneal Stroma","volume":"23","author":"Du","year":"2005","journal-title":"Stem Cells"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16186","DOI":"10.1038\/srep16186","article-title":"Human Corneal Stromal Stem Cells Support Limbal Epithelial Cells Cultured on RAFT Tissue Equivalents","volume":"5","author":"Kureshi","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jtos.2015.12.006","article-title":"Stem Cells in the Limbal Stroma","volume":"14","author":"Funderburgh","year":"2016","journal-title":"Ocul. Surf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1167\/iovs.19-27008","article-title":"Differentiation Capacity of Human Mesenchymal Stem Cells into Keratocyte Lineage","volume":"60","author":"Balayan","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/stem.91","article-title":"Stem Cell Therapy Restores Transparency to Defective Murine Corneas","volume":"27","author":"Du","year":"2009","journal-title":"Stem Cells"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13287-017-0611-5","article-title":"Human Limbal Fibroblast-like Stem Cells Induce Immune-Tolerance in Autoreactive T Lymphocytes from Female Patients with Hashimoto\u2019s Thyroiditis","volume":"8","author":"Coppola","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ali\u00f3, J.L., Ali\u00f3 del Barrio, J.L., and Arnalich-Montiel, F. (2019). Corneal Regeneration: Therapy and Surgery, Springer International Publishing. Essentials in Ophthalmology.","DOI":"10.1007\/978-3-030-01304-2"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/ICO.0000000000001228","article-title":"Cellular Therapy With Human Autologous Adipose-Derived Adult Stem Cells for Advanced Keratoconus","volume":"36","author":"Azaar","year":"2017","journal-title":"Cornea"},{"key":"ref_21","first-page":"3371","article-title":"Limbal Stromal Stem Cell Therapy for Acute and Chronic Superficial Corneal Pathologies: Early Clinical Outcomes of The Funderburgh Technique","volume":"58","author":"Basu","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_22","first-page":"3455","article-title":"Limbal Stromal Stem Cell Therapy for Acute and Chronic Superficial Corneal Pathologies: One-Year Outcomes","volume":"59","author":"Funderburgh","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_23","first-page":"1423","article-title":"Immunological Characterization of Chemical Burn-Induced Ocular Surface Pannus in Humans, Rabbits and Mice after Limbal Stem Cell Deficiency","volume":"58","author":"Singh","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_24","first-page":"8813447","article-title":"Corneal Stem Cells as a Source of Regenerative Cell-Based Therapy","volume":"2020","year":"2020","journal-title":"Stem Cells Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"16950","DOI":"10.1038\/s41598-019-53315-x","article-title":"Encapsulation of Human Limbus-Derived Stromal\/Mesenchymal Stem Cells for Biological Preservation and Transportation in Extreme Indian Conditions for Clinical Use","volume":"9","author":"Damala","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_26","unstructured":"(2022, September 03). The Association for Research in Vision and Ophthalmology-Statement for the Use of Animals in Ophthalmic and Vision Research. Available online: https:\/\/www.arvo.org\/About\/policies\/statement-for-the-use-of-animals-in-ophthalmic-and-vision-research\/#three."},{"key":"ref_27","unstructured":"(2022, November 07). Ich-m-3-R2-Non-Clinical-Safety-Studies-Conduct-Human-Clinical-Trials-Marketing-Authorization_en.Pdf. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-m-3-r2-non-clinical-safety-studies-conduct-human-clinical-trials-marketing-authorization_en.pdf."},{"key":"ref_28","unstructured":"OECD (2021). Test No. 405: Acute Eye Irritation\/Corrosion, Organisation for Economic Co-Operation and Development."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_30","unstructured":"(2022, November 07). Endotoxin Testing Recommendations for Single-Use Intraocular Ophthalmic Devices\u2014Guidance for Industry and Food and Drug Administration Staff. 9, Available online: https:\/\/www.fda.gov\/media\/88615\/download."},{"key":"ref_31","unstructured":"(2022, November 07). Schedule Y(Ammended Version)\u2014CDSCO. 48. Available online: https:\/\/rgcb.res.in\/documents\/Schedule-Y.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.aanat.2012.10.001","article-title":"Schirmer Strip vs. Capillary Tube Method: Non-Invasive Methods of Obtaining Proteins from Tear Fluid","volume":"195","author":"Posa","year":"2013","journal-title":"Ann. Anat.-Anat. Anz. Ann."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"eaba2187","DOI":"10.1126\/sciadv.aba2187","article-title":"LiQD Cornea: Pro-Regeneration Collagen Mimetics as Patches and Alternatives to Corneal Transplantation","volume":"6","author":"McTiernan","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1089\/ten.tea.2020.0019","article-title":"Engineering a Corneal Stromal Equivalent Using a Novel Multilayered Fabrication Assembly Technique","volume":"26","author":"Madden","year":"2020","journal-title":"Tissue Eng. Part A"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jtos.2020.07.020","article-title":"Decellularized Porcine Cornea-Derived Hydrogels for the Regeneration of Epithelium and Stroma in Focal Corneal Defects","volume":"18","author":"Wang","year":"2020","journal-title":"Ocul. Surf."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acsabm.0c01112","article-title":"Prevention of Corneal Myofibroblastic Differentiation In Vitro Using a Biomimetic ECM Hydrogel for Corneal Tissue Regeneration","volume":"4","author":"Chameettachal","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_37","unstructured":"(2022, July 11). WO2019169380A1-Stem Cell-Derived Exosomes for the Treatment of Corneal Scarring\u2014Google Patents. Available online: https:\/\/patents.google.com\/patent\/WO2019169380A1\/en."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2741\/s32","article-title":"TGF Beta in Fibroproliferative Diseases in the Eye","volume":"1","author":"Saika","year":"2009","journal-title":"Front. Biosci.-Sch."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00003226-199805000-00013","article-title":"Effects of PDGF on the Migration of Rabbit Corneal Fibroblasts and Epithelial Cells","volume":"17","author":"Kamiyama","year":"1998","journal-title":"Cornea"},{"key":"ref_40","first-page":"1364","article-title":"Effect of PDGF, IL-1alpha, and BMP2\/4 on Corneal Fibroblast Chemotaxis: Expression of the Platelet-Derived Growth Factor System in the Cornea","volume":"40","author":"Kim","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exer.2017.10.006","article-title":"The Role of Hepatocyte Growth Factor in Corneal Wound Healing","volume":"166","author":"Miyagi","year":"2018","journal-title":"Exp. Eye Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/tvst.9.4.29","article-title":"The Efficacy of Topical HGF on Corneal Fibrosis and Epithelial Healing after Scar-Producing PRK Injury in Rabbits","volume":"9","author":"Murillo","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_43","first-page":"2490","article-title":"Fibroblast Growth Factor Reversal of the Corneal Myofibroblast Phenotype","volume":"42","author":"Maltseva","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","article-title":"Progress in Corneal Wound Healing","volume":"49","author":"Ljubimov","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1167\/iovs.18-24428","article-title":"The Corneal Basement Membranes and Stromal Fibrosis","volume":"59","author":"Medeiros","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"108089","DOI":"10.1016\/j.exer.2020.108089","article-title":"Corneal Wound Healing","volume":"197","author":"Wilson","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biomaterials.2019.01.016","article-title":"Mesenchymal Stem Cell-Derived Extracellular Vesicles and Retinal Ischemia-Reperfusion","volume":"197","author":"Mathew","year":"2019","journal-title":"Biomaterials"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ymthe.2018.05.009","article-title":"Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges","volume":"26","author":"Bagno","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.10.10.3","article-title":"Preclinical Evaluation of the Safety and Efficacy of Cryopreserved Bone Marrow Mesenchymal Stromal Cells for Corneal Repair","volume":"10","author":"Putra","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_50","unstructured":"(2022, November 07). NewDrugs_CTRules_2019.Pdf, Available online: https:\/\/cdsco.gov.in\/opencms\/export\/sites\/CDSCO_WEB\/Pdf-documents\/NewDrugs_CTRules_2019.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/rme.12.7","article-title":"Enhanced Viability of Corneal Epithelial Cells for Efficient Transport\/Storage Using a Structurally Modified Calcium Alginate Hydrogel","volume":"7","author":"Wright","year":"2012","journal-title":"Regen. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/6\/876\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:52:43Z","timestamp":1760122363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/6\/876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["cells12060876"],"URL":"https:\/\/doi.org\/10.3390\/cells12060876","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,11]]}}}